We have recently demonstrated that ibuprofen reduces vascular growth factors, such as PDGF-BB, VEGF-A and HIF-2ɑ, in infants with PDA [59], confirming that the anti-angiogenic effect of ibuprofen is already present in human infants exposed for 3 days. Here, VEGFA is linked to Patent ductus arteriosus.